Sequential studies of glucose tolerance and red blood cell insulin receptors in normal human pregnancy
Sequential studies of glucose tolerance and red blood cell insulin receptors in normal human pregnancy. A C Lerario , B L Wajchenberg , W el-Andere , L Y Ohnuma , J Monaci , M Sankowsky , I T Toledo , E Souza and O Germek Abstract Insulin binding to erythrocytes was sequentially studied in 12 health...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 34; no. 8; pp. 780 - 786 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Diabetes Association
01.08.1985
|
Online Access | Get full text |
Cover
Loading…
Summary: | Sequential studies of glucose tolerance and red blood cell insulin receptors in normal human pregnancy.
A C Lerario ,
B L Wajchenberg ,
W el-Andere ,
L Y Ohnuma ,
J Monaci ,
M Sankowsky ,
I T Toledo ,
E Souza and
O Germek
Abstract
Insulin binding to erythrocytes was sequentially studied in 12 healthy pregnant women during the anabolic (11-22 wk) and the
catabolic (31-38 wk) gestational phases. For comparison, we studied 12 nonpregnant subjects at mid-luteal and mid-follicular
menstrual phases. Oral glucose tolerance tests were also performed during these studies. There was a progressive worsening
of the glucose tolerance from the anabolic to the catabolic phase associated with fasting hypoglycemia and hyperinsulinemia.
The worsening of glucose tolerance was accompanied by a progressive increment of insulin secretion. Insulin binding to red
blood cells increased progressively from the anabolic to the catabolic phase, due to an increased number of receptors per
cell, associated with a reduction in the apparent affinity at the low occupancy levels. We concluded that the insulin resistance
of pregnancy was not accompanied by an impaired binding of insulin to its receptors, at least in the RBC. The data suggest
that the defect of insulin action lies at a site distal to the receptor. |
---|---|
ISSN: | 0012-1797 1939-327X 0012-1797 |
DOI: | 10.2337/diabetes.34.8.780 |